Research Journal of Pharmaceutical Dosage Forms and Technology
  • Year: 2021
  • Volume: 13
  • Issue: 1

The CRISPR genome editing process is an effective advancement of short-term cancer treatment

1Department of Anatomy, College of Medicine, University of Mosul, Mosul, Iraq

2Department of Internal Medicine, College of Medicine, University of Nineveh, Mosul, Iraq

*Corresponding Author E-mail: aad@uomosul.edu.iq

Online published on 4 May, 2021.

Abstract

The CRISPR method is considered the biggest biotechnology breakthrough of the century because of its accuracy, effectiveness, and versatility, and it has opened up new possibilities for micro-genome editing and in vivo imaging. Overall, the technology of CRISPR / Cas9 has demonstrated unparalleled therapeutic promise to study and target diseases and to include innovative methods for drug development. To kill cancer cells, scientists are creating a groundbreaking CRISPER based genome editing treatment. A big step in the road to finding a cure for cancer is this recent growth. With other variants of CRISPR, scientists can change genes in more complex ways, such as inserting a new DNA segment or modifying single DNA letters.

Keywords

CRISPER, Cancer, Cas9, Mrna, Glioblastoma